SyntekaBio (XKRX:226330) Operating Cash Flow per Share : ₩-652.14 (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Operating Cash Flow per Share?

SyntekaBio's operating cash flow per share for the three months ended in Mar. 2025 was ₩-148.69. SyntekaBio's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-652.14.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -15.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for SyntekaBio's Operating Cash Flow per Share or its related term are showing as below:

XKRX:226330' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -24.3 Med: -15.4 Max: 17.9
Current: -15.4

During the past 8 years, SyntekaBio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.90% per year. The lowest was -24.30% per year. And the median was -15.40% per year.

XKRX:226330's 3-Year OCF Growth Rate is ranked worse than
81.75% of 526 companies
in the Healthcare Providers & Services industry
Industry Median: 7.95 vs XKRX:226330: -15.40

SyntekaBio Operating Cash Flow per Share Historical Data

The historical data trend for SyntekaBio's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Operating Cash Flow per Share Chart

SyntekaBio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-352.57

-448.64

-628.89

-564.15

-688.74

SyntekaBio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-183.87	-105.61	-192.07	-205.78	-148.69

Competitive Comparison of SyntekaBio's Operating Cash Flow per Share

For the Health Information Services subindustry, SyntekaBio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SyntekaBio's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SyntekaBio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SyntekaBio's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

SyntekaBio Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

SyntekaBio's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-10508.849	/	15.258
	=	-688.74

SyntekaBio's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-3054.381	/	20.542
	=	-148.69

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-652.14

SyntekaBio Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of SyntekaBio's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

SyntekaBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512

Website

http://www.syntekabio.co.kr

SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio Headlines

No Headlines